{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:13:06Z","timestamp":1758424386892,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":1282,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jtcvs.2012.09.032","type":"journal-article","created":{"date-parts":[[2012,10,13]],"date-time":"2012-10-13T04:59:50Z","timestamp":1350104390000},"page":"243-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Coronary artery bypass grafting after aprotinin: Are we doing better?"],"prefix":"10.1016","volume":"145","author":[{"given":"Ziv","family":"Beckerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoni","family":"Shopen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagar","family":"Alon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oved","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rony-Reuven","family":"Nir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvi","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Bolotin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2012.09.032_bib1","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.297.5.471","article-title":"Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery","volume":"297","author":"Mangano","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib3","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1538-7836.2007.02717.x","article-title":"Evaluation of aprotinin and tranexamic acid in different in\u00a0vitro and in\u00a0vivo models of fibrinolysis, coagulation and thrombus formation","volume":"5","author":"Sperzel","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jtcvs.2004.03.041","article-title":"Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials","volume":"128","author":"Sedrakyan","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00000542-200208000-00016","article-title":"Pharmacokinetics of tranexamic acid during cardiopulmonary bypass","volume":"97","author":"Dowd","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejcts.2008.11.038","article-title":"Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial","volume":"36","author":"Later","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib7","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/S0003-4975(99)00866-8","article-title":"Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery","volume":"68","author":"Casati","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib8","first-page":"231","article-title":"Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery: prospective trial of 3 antifibrinolytic drugs","volume":"22","author":"Penta de Peppo","year":"1995","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1540-8191.1999.tb00956.x","article-title":"Reduction of blood loss and transfusion requirements after coronary artery bypass grafting: similar efficacy of tranexamic acid and aprotinin in aspirin-treated patients","volume":"14","author":"Bernet","year":"1999","journal-title":"J Card Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0022-5223(12)70192-7","article-title":"Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass","volume":"108","author":"Blauhut","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib11","first-page":"363","article-title":"Fibrinolytic inhibitors and prevention of bleeding in cardiac valve surgery: comparison of tranexamic acid and high dose aprotinin","volume":"88","author":"Boughenou","year":"1995","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1067\/mtc.2000.108016","article-title":"Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions","volume":"120","author":"Casati","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0750-7658(95)70013-2","article-title":"Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery","volume":"14","author":"Corbeau","year":"1995","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/bja\/aei044","article-title":"Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage","volume":"94","author":"Diprose","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1185\/030079903125002658","article-title":"Impact of tranexamic acid vs aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial","volume":"20","author":"Hekmat","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib16","first-page":"224","article-title":"Antifibrinolytic treatment and homologous transfusion in cardiac surgery","volume":"14","author":"Isetta","year":"1993","journal-title":"Eur Heart J"},{"issue":"9 Suppl","key":"10.1016\/j.jtcvs.2012.09.032_bib17","article-title":"Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery","volume":"96","author":"Jamieson","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib18","first-page":"401","article-title":"Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid","volume":"37","author":"Menichetti","year":"1996","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1213\/00000539-199808000-00005","article-title":"Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization","volume":"87","author":"Mongan","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00000542-200003000-00010","article-title":"Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding","volume":"92","author":"Nuttall","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0003-4975(99)01419-8","article-title":"Aprotinin and tranexamic acid for high transfusion risk cardiac surgery","volume":"69","author":"Wong","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib22","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.athoracsur.2010.02.006","article-title":"Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery","volume":"89","author":"Wang","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib23","first-page":"621","article-title":"The use of micro-dose aprotinin with continuous infusion in coronary artery bypass surgery","volume":"40","author":"Holmes","year":"1999","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2165\/00002018-200831070-00007","article-title":"Safety of low-dose aprotinin in coronary artery bypass graft surgery: a single-centre investigation in 2,436 patients in Germany","volume":"31","author":"Kluth","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib25","first-page":"10","article-title":"Efficacy of minimal dose aprotinin in open heart procedures","volume":"2","author":"Maddali","year":"1999","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/cc9216","article-title":"Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis","volume":"14","author":"Sander","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib27","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1213\/ane.0b013e318182252b","article-title":"Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin","volume":"107","author":"Dietrich","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0003-4975(96)00317-7","article-title":"Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass","volume":"62","author":"Terrell","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2012.09.032_bib29","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00005344-199905000-00007","article-title":"Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis","volume":"33","author":"Lockyer","year":"1999","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522312011440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522312011440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:51:52Z","timestamp":1758387112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522312011440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0022522312011440"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2012.09.032","relation":{},"ISSN":["0022-5223"],"issn-type":[{"type":"print","value":"0022-5223"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary artery bypass grafting after aprotinin: Are we doing better?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2012.09.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}